KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 74 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $113,436 | -47.0% | 14,432 | +61.8% | 0.00% | -100.0% |
| Q2 2021 | $214,000 | -64.9% | 8,919 | -62.4% | 0.00% | -75.0% |
| Q1 2021 | $610,000 | +238.9% | 23,741 | +59.8% | 0.00% | +33.3% |
| Q2 2020 | $180,000 | -69.0% | 14,853 | -80.4% | 0.00% | -80.0% |
| Q1 2020 | $581,000 | -73.5% | 75,910 | -38.3% | 0.02% | +15.4% |
| Q4 2019 | $2,191,000 | +52.5% | 123,043 | -0.7% | 0.01% | 0.0% |
| Q3 2019 | $1,437,000 | -8.9% | 123,887 | +73.9% | 0.01% | -13.3% |
| Q2 2019 | $1,578,000 | – | 71,244 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,579,490 | $20,146,000 | 22.25% |
| Novo Holdings A/S | 2,901,927 | $22,664,000 | 2.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 322,436 | $2,518,000 | 0.96% |
| Vivo Capital, LLC | 300,325 | $2,346,000 | 0.69% |
| VHCP Management II, LLC | 221,651 | $1,635,000 | 0.67% |
| RA Capital Management | 591,070 | $4,616,000 | 0.57% |
| INTERWEST VENTURE MANAGEMENT CO | 329,942 | $2,577,000 | 0.55% |
| Eventide Asset Management | 98,100 | $766,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 21,665 | $169,000 | 0.03% |
| A.R.T. Advisors, LLC | 11,116 | $86,000 | 0.00% |